ciprofloxacin has been researched along with Myelodysplastic Syndromes in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a single-center open-label prospective study, a total of 134 marrow transplant recipients with hematologic malignancies were randomly assigned to a bacterial decontamination medication using metronidazole and ciprofloxacin (n = 68) or ciprofloxacin alone (n = 66) during 5 weeks posttransplant." | 9.09 | Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and ( Beelen, DW; Elmaagacli, A; Hirche, H; Müller, KD; Schaefer, UW, 1999) |
| "In a single-center open-label prospective study, a total of 134 marrow transplant recipients with hematologic malignancies were randomly assigned to a bacterial decontamination medication using metronidazole and ciprofloxacin (n = 68) or ciprofloxacin alone (n = 66) during 5 weeks posttransplant." | 5.09 | Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and ( Beelen, DW; Elmaagacli, A; Hirche, H; Müller, KD; Schaefer, UW, 1999) |
| "Tumor necrosis factor-alpha (TNF-alpha) levels were measured in the serum (sTNF-alpha) or bone marrow (BM) biopsies of 43 patients with myelodysplastic syndromes (MDS) who subsequently received therapy with a combination of pentoxifylline and ciprofloxacin (PC) with or without dexamethasone (PCD)." | 5.08 | Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes. ( Dar, S; Qawi, H; Raza, A; Reza, S; Shetty, V, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zlitni, S | 1 |
| Bishara, A | 1 |
| Moss, EL | 1 |
| Tkachenko, E | 1 |
| Kang, JB | 1 |
| Culver, RN | 1 |
| Andermann, TM | 1 |
| Weng, Z | 1 |
| Wood, C | 1 |
| Handy, C | 1 |
| Ji, HP | 1 |
| Batzoglou, S | 1 |
| Bhatt, AS | 1 |
| Gagneux-Brunon, A | 1 |
| Pillet, S | 1 |
| Laurent, B | 1 |
| Mariat, C | 1 |
| Michalet, M | 1 |
| Lucht, F | 1 |
| Botelho-Nevers, E | 1 |
| Erikci, AA | 1 |
| Ozturk, A | 1 |
| Karagoz, B | 1 |
| Bilgi, O | 1 |
| Turken, O | 1 |
| Top, C | 1 |
| Kandemir, EG | 1 |
| Smith, RE | 1 |
| Bryant, J | 1 |
| DeCillis, A | 1 |
| Anderson, S | 1 |
| Kim, MK | 1 |
| Lee, JL | 1 |
| Cho, HS | 1 |
| Bae, SH | 1 |
| Ryoo, HM | 1 |
| Lee, KH | 1 |
| Hyun, MS | 1 |
| Nemunaitis, J | 1 |
| Rosenfeld, C | 1 |
| Getty, L | 1 |
| Boegel, F | 1 |
| Meyer, W | 1 |
| Jennings, LW | 1 |
| Zeigler, Z | 1 |
| Shadduck, R | 1 |
| Reza, S | 1 |
| Shetty, V | 1 |
| Dar, S | 2 |
| Qawi, H | 2 |
| Raza, A | 2 |
| Beelen, DW | 1 |
| Elmaagacli, A | 1 |
| Müller, KD | 1 |
| Hirche, H | 1 |
| Schaefer, UW | 1 |
| Lisak, L | 1 |
| Andric, T | 1 |
| Andrews, C | 1 |
| Venugopal, P | 1 |
| Gezer, S | 1 |
| Gregory, S | 1 |
| Loew, J | 1 |
| Robin, E | 1 |
| Rifkin, S | 1 |
| Hsu, WT | 1 |
| Huang, RW | 1 |
| Novitzky, N | 1 |
| Mohamed, R | 1 |
| Finlayson, J | 1 |
| du Toit, C | 1 |
4 trials available for ciprofloxacin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
The hematologic response to anti-apoptotic cytokine therapy: results of pentoxifylline, ciprofloxacin, and dexamethasone treatment for patients with myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Apoptosis; Ciprofloxacin; | 2006 |
Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial.
Topics: Adult; Aged; Ciprofloxacin; Colony-Forming Units Assay; Drug Therapy, Combination; Female; Hematopoi | 1995 |
Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Biopsy; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Female; He | 1998 |
Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, | 1999 |
6 other studies available for ciprofloxacin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale.
Topics: Anti-Infective Agents; Azacitidine; Azithromycin; Bacteria; Ciprofloxacin; Diet; DNA, Bacterial; Fec | 2020 |
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplant | 2015 |
Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Dexamethason | 2008 |
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cipr | 2003 |
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols | 2000 |
Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes.
Topics: Anti-Inflammatory Agents; Antigens, CD34; Apoptosis; Blood Transfusion; Bone Marrow Cells; Cell Divi | 2000 |